Compare
Streamex Corp. vs Ceribell, Inc. vs Axogen, Inc. vs Outset Medical, Inc.
| Latest fiscal year | Streamex Corp. STEX | Ceribell, Inc. CBLL | Axogen, Inc. AXGN | Outset Medical, Inc. OM |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $89.06M | $225.21M | $119.48M |
| Revenue growth (YoY) | n/a | +36.1% | +20.2% | +5.1% |
| Gross margin | n/a | 87.9% | 74.3% | 39.1% |
| Operating margin | n/a | -65.6% | -3.5% | -55.8% |
| Net margin | n/a | -60.0% | -7.0% | -68.3% |
| Net income | -$462.77M | -$53.41M | -$15.70M | -$81.65M |
| EPS (Diluted) | -$9.65 | -$1.46 | -$0.34 | -$5.37 |
| Operating cash flow | -$10.44M | -$40.81M | $812.0K | -$46.33M |
| Free cash flow | n/a | -$41.58M | -$2.93M | -$47.12M |
| Cash & equivalents | $20.30M | $40.48M | $35.55M | $35.01M |
| Total assets | $187.54M | $195.80M | $221.69M | $264.50M |
| Total liabilities | $54.22M | $40.47M | $92.84M | $137.54M |
| Shareholders' equity | $133.19M | $155.34M | $128.85M | $126.95M |
| Return on year-end equity | -347.5% | -34.4% | -12.2% | -64.3% |
| Shares outstanding | 49.81M | 37.49M | 47.20M | 18.17M |
Revenue, most recent five fiscal years
| Fiscal year | Streamex Corp. | Ceribell, Inc. | Axogen, Inc. | Outset Medical, Inc. |
|---|---|---|---|---|
| Latest | $40.0K Ended 2024-12-31 | $89.06M Ended 2025-12-31 | $225.21M Ended 2025-12-31 | $119.48M Ended 2025-12-31 |
| 1 year earlier | $18.0K Ended 2023-12-31 | $65.44M Ended 2024-12-31 | $187.34M Ended 2024-12-31 | $113.69M Ended 2024-12-31 |
| 2 years earlier | $286.0K Ended 2022-12-31 | $45.23M Ended 2023-12-31 | $159.01M Ended 2023-12-31 | $130.38M Ended 2023-12-31 |
| 3 years earlier | $441.0K Ended 2021-12-31 | n/a | $138.58M Ended 2022-12-31 | $115.38M Ended 2022-12-31 |
| 4 years earlier | $0 Ended 2020-12-31 | n/a | $127.36M Ended 2021-12-31 | $102.60M Ended 2021-12-31 |